Viewing Study NCT01736761


Ignite Creation Date: 2025-12-24 @ 12:01 PM
Ignite Modification Date: 2026-01-03 @ 12:20 AM
Study NCT ID: NCT01736761
Status: COMPLETED
Last Update Posted: 2017-06-16
First Post: 2012-11-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.
Sponsor: St Stephens Aids Trust
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module